デフォルト表紙
市場調査レポート
商品コード
1596771

構造生物学・分子モデリング技術市場:ツール別、用途別-2025-2030年の世界予測

Structural Biology & Molecular Modeling Techniques Market by Tools (Databases, SaaS & Standalone Modeling, Visualization & Analysis), Application (Drug Development, Drug Discovery) - Global Forecast 2025-2030


出版日
発行
360iResearch
ページ情報
英文 196 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
構造生物学・分子モデリング技術市場:ツール別、用途別-2025-2030年の世界予測
出版日: 2024年10月31日
発行: 360iResearch
ページ情報: 英文 196 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

構造生物学・分子モデリング技術市場は、2023年に93億9,000万米ドルと評価され、2024年には111億米ドルに達すると予測され、CAGR 18.34%で成長し、2030年には305億2,000万米ドルに達すると予測されています。

構造生物学と分子モデリングは、生物学的プロセスを原子レベルで理解する上で極めて重要であり、創薬研究開発、遺伝子研究、バイオテクノロジーに不可欠な知見を提供します。X線結晶構造解析、NMR分光法、極低温電子顕微鏡法などの先端技術を駆使して高分子の構造を可視化し、分子動力学シミュレーションやホモロジー・モデリングなどの計算科学的手法で分子の挙動や相互作用を予測します。これらの技術は、製薬企業にとっては薬剤設計や主要企業の最適化、学術機関にとっては包括的な生物学的研究、バイオテクノロジー企業にとっては新規治療戦略の開発において極めて重要です。

主な市場の統計
基準年[2023] 93億9,000万米ドル
予測年[2024] 111億米ドル
予測年[2030] 305億2,000万米ドル
CAGR(%) 18.34%

構造生物学と分子モデリングの市場は、標的治療と個別化医療に対する需要の増加、高度な研究アプローチを必要とする疾患の複雑化、イメージングと計算技術の技術的進歩が主な要因です。潜在的な機会は、予測モデリングのためのAIと機械学習の統合、データ共有とコラボレーションの強化のためのクラウドベースのツールの拡大、詳細な構造解析を必要とする生物製剤とバイオシミラーの成長にあります。しかし、機器の高コスト、データ解釈の複雑さ、高度に熟練した人材の必要性といった課題は、市場の成長を制限する可能性があります。

費用対効果の高い技術の開発、データ処理と分析パイプラインの自動化、農業バイオテクノロジーや環境科学などの非医薬品分野での応用拡大など、技術革新の機会は豊富にあります。市場の競争力を維持するためには、継続的な適応と研究開発への投資を必要とする急速な進歩が特徴です。企業への提言としては、戦略的パートナーシップを優先すること、スキルギャップを埋めるためのトレーニングプログラムに注力すること、進化する科学的ニーズに対応できるスケーラブルな技術に投資することなどが挙げられます。このような障壁があるにもかかわらず、革新的な治療法の設計における分子モデリングの範囲は拡大しており、最新の研究室では不可欠であることから、成長と開発の大きな展望が開けています。

市場力学:急速に進化する構造生物学・分子モデリング技術市場の主要市場インサイトを公開

構造生物学・分子モデリング技術市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

  • 市場促進要因
    • 後天性薬剤耐性による慢性疾患の増加
    • 医薬品開発における高い薬剤減少率と後期臨床試験に起因する需要の増加
    • 予測ソフトウェアの使用による薬剤の失敗確率の減少
  • 市場抑制要因
    • 装置の相対的な高コストと低開発国における十分な設備の欠如
  • 市場機会
    • 新規リード化合物の同定に有効な数理モデルの開発による新たな技術革新
    • 生物医学研究による創薬プロセスの最適化に関する研究開発の増加
  • 市場の課題
    • 熟練した専門家の不足

ポーターの5つの力:構造生物学・分子モデリング技術市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析:構造生物学・分子モデリング技術市場における外部からの影響の把握

外部マクロ環境要因は、構造生物学・分子モデリング技術市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析構造生物学・分子モデリング技術市場における競合情勢の把握

構造生物学・分子モデリング技術市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス構造生物学・分子モデリング技術市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、構造生物学・分子モデリング技術市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨構造生物学・分子モデリング技術市場における成功への道筋を描く

構造生物学・分子モデリング技術市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています:

1.市場の浸透度:現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度:新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化:最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報:競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション:将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています:

1.現在の市場規模と今後の成長予測は?

2.最高の投資機会を提供する製品、セグメント、地域はどこか?

3.市場を形成する主な技術動向と規制の影響とは?

4.主要ベンダーの市場シェアと競合ポジションは?

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 慢性疾患の発生率の増加と薬剤耐性の獲得
      • 医薬品開発における薬剤中止率の高さと臨床試験後期化により需要が増加
      • 予測ソフトウェアの使用により薬剤の失敗確率が減少
    • 抑制要因
      • 比較的高価な機器と、発展途上国における十分な設備の不足
    • 機会
      • 新たなリードを特定するための検証済みの数学モデルの開発による新たな技術革新
      • バイオメディカル調査による創薬プロセスの最適化の進展
    • 課題
      • 熟練した専門家の不足
  • 市場セグメンテーション分析
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治的
    • 経済
    • 社交
    • 技術的
    • 法律上
    • 環境

第6章 構造生物学・分子モデリング技術市場ツール別

  • データベース
  • SaaSとスタンドアロンモデリング
    • 抗体
    • ホモロジーモデリング
    • ハイブリッド
    • 分子動力学
    • スレッド
  • 視覚化と分析

第7章 構造生物学・分子モデリング技術市場:用途別

  • 医薬品開発
  • 創薬

第8章 南北アメリカの構造生物学・分子モデリング技術市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域の構造生物学・分子モデリング技術市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカの構造生物学・分子モデリング技術市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
  • 戦略分析と提言

企業一覧

  • Acellera Ltd.
  • Agilent Technologies, Inc.
  • Biomax Informatics AG
  • Bruker Corporation
  • Chemical Computing Group ULC
  • Dassault Systemes
  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
図表

LIST OF FIGURES

  • FIGURE 1. STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET RESEARCH PROCESS
  • FIGURE 2. STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET DYNAMICS
  • TABLE 7. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DATABASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY HOMOLOGY MODELING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY HYBRID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY MOLECULAR DYNAMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY THREADING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY VISUALIZATION & ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 148. STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-AD36CD8984FF

The Structural Biology & Molecular Modeling Techniques Market was valued at USD 9.39 billion in 2023, expected to reach USD 11.10 billion in 2024, and is projected to grow at a CAGR of 18.34%, to USD 30.52 billion by 2030.

Structural biology and molecular modeling are pivotal to understanding biological processes at an atomic level, offering vital insights for drug discovery and development, genetic research, and biotechnology. The scope encompasses the use of advanced techniques such as X-ray crystallography, NMR spectroscopy, and cryo-electron microscopy for visualizing macromolecular structures, complemented by computational methods like molecular dynamics simulations and homology modeling to predict molecular behavior and interactions. These techniques are crucial for pharmaceutical companies in drug design and lead optimization, academic institutions for comprehensive biological research, and biotech firms for developing novel therapeutic strategies.

KEY MARKET STATISTICS
Base Year [2023] USD 9.39 billion
Estimated Year [2024] USD 11.10 billion
Forecast Year [2030] USD 30.52 billion
CAGR (%) 18.34%

The market for structural biology and molecular modeling is primarily driven by the increasing demand for targeted therapies and personalized medicine, the complexity of diseases necessitating advanced research approaches, and technological advancements in imaging and computational techniques. Potential opportunities lie in the integration of AI and machine learning for predictive modeling, expansion of cloud-based tools for enhanced data sharing and collaboration, and the growth of biologics and biosimilars demanding detailed structural analysis. However, challenges like high costs of equipment, the complexity of data interpretation, and the need for highly skilled personnel can restrict market growth.

Innovation opportunities are abundant in developing cost-effective technologies, automating data processing and analysis pipelines, and expanding applications in non-pharmaceutical sectors such as agricultural biotechnology and environmental sciences. The market is characterized by rapid advancements requiring continuous adaptation and investment in R&D to maintain competitiveness. Recommendations for businesses include prioritizing strategic partnerships, focusing on training programs to bridge the skill gap, and investing in scalable technologies that can cater to evolving scientific needs. Despite the barriers, the expanding scope of molecular modeling in innovative therapeutic design and its indispensability in modern research laboratories present substantial prospects for growth and development.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Structural Biology & Molecular Modeling Techniques Market

The Structural Biology & Molecular Modeling Techniques Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing incidences of chronic diseases coupled with acquired drug resistance property
    • Increasing demand attributed to high drug attrition rate and late-phase clinical trials in drug development
    • Reduced probability of drug failure with use of prediction software
  • Market Restraints
    • Relatively high cost of the equipment and lack of sufficient facilities in underdeveloped countries
  • Market Opportunities
    • Emerging technological innovations with the development of validated mathematical models for identification of novel leads
    • Increasing developments in optimization of drug discovery process with biomedical research
  • Market Challenges
    • Dearth of skilled professional

Porter's Five Forces: A Strategic Tool for Navigating the Structural Biology & Molecular Modeling Techniques Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Structural Biology & Molecular Modeling Techniques Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Structural Biology & Molecular Modeling Techniques Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Structural Biology & Molecular Modeling Techniques Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Structural Biology & Molecular Modeling Techniques Market

A detailed market share analysis in the Structural Biology & Molecular Modeling Techniques Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Structural Biology & Molecular Modeling Techniques Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Structural Biology & Molecular Modeling Techniques Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Structural Biology & Molecular Modeling Techniques Market

A strategic analysis of the Structural Biology & Molecular Modeling Techniques Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Structural Biology & Molecular Modeling Techniques Market, highlighting leading vendors and their innovative profiles. These include Acellera Ltd., Agilent Technologies, Inc., Biomax Informatics AG, Bruker Corporation, Chemical Computing Group ULC, Dassault Systemes, Illumina, Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Structural Biology & Molecular Modeling Techniques Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Tools, market is studied across Databases, SaaS & Standalone Modeling, and Visualization & Analysis. The SaaS & Standalone Modeling is further studied across Antibodies, Homology Modeling, Hybrid, Molecular Dynamics, and Threading.
  • Based on Application, market is studied across Drug Development and Drug Discovery.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidences of chronic diseases coupled with acquired drug resistance property
      • 5.1.1.2. Increasing demand attributed to high drug attrition rate and late-phase clinical trials in drug development
      • 5.1.1.3. Reduced probability of drug failure with use of prediction software
    • 5.1.2. Restraints
      • 5.1.2.1. Relatively high cost of the equipment and lack of sufficient facilities in underdeveloped countries
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging technological innovations with the development of validated mathematical models for identification of novel leads
      • 5.1.3.2. Increasing developments in optimization of drug discovery process with biomedical research
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of skilled professional
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Structural Biology & Molecular Modeling Techniques Market, by Tools

  • 6.1. Introduction
  • 6.2. Databases
  • 6.3. SaaS & Standalone Modeling
    • 6.3.1. Antibodies
    • 6.3.2. Homology Modeling
    • 6.3.3. Hybrid
    • 6.3.4. Molecular Dynamics
    • 6.3.5. Threading
  • 6.4. Visualization & Analysis

7. Structural Biology & Molecular Modeling Techniques Market, by Application

  • 7.1. Introduction
  • 7.2. Drug Development
  • 7.3. Drug Discovery

8. Americas Structural Biology & Molecular Modeling Techniques Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Structural Biology & Molecular Modeling Techniques Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Structural Biology & Molecular Modeling Techniques Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Acellera Ltd.
  • 2. Agilent Technologies, Inc.
  • 3. Biomax Informatics AG
  • 4. Bruker Corporation
  • 5. Chemical Computing Group ULC
  • 6. Dassault Systemes
  • 7. Illumina, Inc.
  • 8. Thermo Fisher Scientific Inc.